Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 06:06 am Purchase | 13G | GRAPHITE BIO INC GRPH | Samsara BioCapital L.P. | 7,851,933 13.5% | 420,310 (+5.66%) | View |
| 2021-07-09 4:31 pm Purchase | 13G | GRAPHITE BIO INC GRPH | Samsara BioCapital L.P. | 7,431,623 12.8% | 7,431,623 (New Position) | View |
| 2020-07-22 3:33 pm Purchase | 13D | NKARTA INC NKTX | Samsara BioCapital L.P. | 2,034,703 6.3% | 2,034,703 (New Position) | View |
| 2020-03-06 4:00 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | Samsara BioCapital L.P. | 2,161,333 5.2% | 2,161,333 (New Position) | View |
| 2020-03-05 4:13 pm Purchase | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS | Samsara BioCapital L.P. | 5,938,215 5.3% | 5,938,215 (New Position) | View |